incretin mimetics glp 1 agonists Incretins: How we got here, where we're at and what is coming next Medicinal Chemistry of Incretin Mimetics

Cost, coverage, and access can vary widely between the medications, depending on factors that arent always clear upfront

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm2018 executive summary

While the benefits are undeniable, the blockbuster growth and use of GLP-1 drugs has also highlighted potential side effects

doi: 10.1037/amp0000059 [DOI] [PMC free article] [PubMed] [Google Scholar] 149.Volkow ND

CVD: Cardiovascular Disease

In 2002, a 6-week subcutaneous infusion of GLP-1 showed a robust glucose-lowering effect in patients with type 2 diabetes [6]